Jcovden (previously COVID-19 Vaccine Janssen) Európska únia - fínčina - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - rokotteet - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

Rybrevant Európska únia - fínčina - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Carvykti Európska únia - fínčina - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multiple myeloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Tecvayli Európska únia - fínčina - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastiset aineet - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Akeega Európska únia - fínčina - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - eturauhasen kasvaimet, kastraatio-resistentin - antineoplastiset aineet - treatment of adult patients with prostate cancer.

Talvey Európska únia - fínčina - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastiset aineet - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Takhzyro Európska únia - fínčina - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedeema, perinnöllinen - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Firazyr Európska únia - fínčina - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - ikatibanttia - angioedeema, perinnöllinen - sydämen hoito - firazyr on tarkoitettu aikuisten perinnöllisten angioödeemien (hae) akuuttien hyökkäysten oireenmukaiseen hoitoon (c1-esteraasi-inhibiittorin puutos).

SEDAMAN VET 200 mg/ml injektioneste, liuos Fínsko - fínčina - Fimea (Suomen lääkevirasto)

sedaman vet 200 mg/ml injektioneste, liuos

orion corporation - magnesium sulfas - injektioneste, liuos - 200 mg/ml - magnesiumsulfaatti

Ghemaxan 10 000 IU (100 mg) / 1 ml injektioneste, liuos, esitäytetty ruisku Fínsko - fínčina - Fimea (Suomen lääkevirasto)

ghemaxan 10 000 iu (100 mg) / 1 ml injektioneste, liuos, esitäytetty ruisku

chemi s.p.a. - enoxaparin sodium - injektioneste, liuos, esitäytetty ruisku - 10 000 iu (100 mg) / 1 ml - enoksapariini